Evolution and transmission patterns of extensively drug-resistant tuberculosis in China

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 2, 2015, Pages 818-825

  Wang, Feifei ^a,b   Shao, Lingyun ^a   Fan, Xiaoping ^a   Shen, Yaojie ^a   Diao, Ni ^a   Jin, Jialin ^a   Sun, Feng ^a   Wu, Jing ^a   Chen, Jiazhen ^a   Weng, Xinhua ^a   Cheng, Xunjia ^b   Zhang, Ying ^a,c   Zhang, Wenhong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPREOMYCIN; ETHAMBUTOL; ISONIAZID; KANAMYCIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; BACTERIAL PROTEIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHINA; DISEASE COURSE; DISEASE TRANSMISSION; DNA SEQUENCE; EMBB GENE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; GENE CLUSTER; GENE LOCUS; GENE MUTATION; GENOTYPE; GIDB GENE; HUMAN; INHA GENE; KATG GENE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RPOB GENE; RPSL GENE; VARIABLE NUMBER OF TANDEM REPEAT; EPIDEMIOLOGY; EVOLUTION; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; GENETICS; METABOLISM; MULTIDRUG RESISTANCE; TRANSMISSION; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BIOLOGICAL EVOLUTION; CHINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84921799544     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03504-14     Document Type: Article

References (41)

1. REFERENCES
2. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, Jensen P, Bayona J. 2010. Multidrug-resistant and extensively drugresistant tuberculosis: a threat to global control of tuberculosis. Lancet 375:1830-1843. http://dx.doi.org/10.1016/S0140-6736(10)60410-2.
3. Centers for Disease Control and Prevention. 2006. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugsworldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 55:301-305.
4. Raviglione MC, Smith IM. 2007. XDR tuberculosis-implications for global public health. N Engl J Med 356:656-659. http://dx.doi.org/10 .1056/NEJMp068273.
5. WHO. 2012. Global tuberculosis control report 2012. World Health Organization, Geneva, Switzerland. http://apps.who.int/iris/bitstream /10665/75938/1/9789241564502-eng.pdf.
6. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G. 2006. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368:1575-1580. http://dx.doi .org/10.1016/S0140-6736(06)69573-1.
7. Kim HR, Hwang SS, Kim HJ, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ. 2007. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Clin Infect Dis 45:1290-1295. http://dx.doi.org/10.1086/522537.
8. Singh JA, Upshur R, Padayatchi N. 2007. XDR-TB in South Africa: no time for denial or complacency. PLoS Med 4:e50. http://dx.doi.org/10 .1371/journal.pmed.0040050.
9. Ioerger TR, Feng Y, Chen X, Dobos KM, Victor TC, Streicher EM, Warren RM, Gey van Pittius NC, Van Helden PD, Sacchettini JC. 2010. The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa. BMC Genomics 11:670. http://dx.doi.org/10.1186/1471-2164-11-670.
10. Toungoussova OS, Caugant DA, Sandven P, Mariandyshev AO, Bjune G. 2004. Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype. FEMS Immunol Med Microbiol 42:281-290. http://dx.doi.org/10.1016/j.femsim.2004.05.012.
11. Iwamoto T, Yoshida S, Suzuki K, Wada T. 2008. Population structure analysis of the Mycobacterium tuberculosis Beijing family indicates an association between certain sublineages and multidrug resistance. Antimicrob Agents Chemother 52:3805-3809. http://dx.doi.org/10.1128/AAC .00579-08.
12. CDC. 1991. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons-Florida and New York, 1988 -1991. MMWR Morb Mortal Wkly Rep 40:585-591.
13. Edlin BR, Tokars JI, Grieco MH, Crawford JT, Williams J, Sordillo EM, Ong KR, Kilburn JO, Dooley SW, Castro KG, Jarvis WR, Holmberg SD. 1992. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 326:1514-1521. http://dx.doi.org/10.1056/NEJM199206043262302.
14. Rullán JV, Herrera D, Cano R, Moreno V, Godoy P, Peiró EF, Castell J, Ibañez C, Ortega A, Agudo LS, Pozo F. 1996. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spain. Emerg Infect Dis 2:125-129. http://dx.doi.org/10.3201/eid0202.960208.
15. Gandhi NR, Weissman D, Moodley P, Ramathal M, Elson I, Kreiswirth BN, Mathema B, Shashkina E, Rothenberg R, Moll AP, Friedland G, Sturm AW, Shah NS. 2013. Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa. J Infect Dis 207:9-17. http://dx.doi.org/10.1093/infdis/jis631.
16. Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, Xia H, Zhou Y, Li Q, Ou X, Pang Y, Song Y, Zhao B, Zhang H, He G, Guo J, Wang Y. 2012. National survey of drug-resistant tuberculosis in China. N Engl J Med 366:2161-2170. http://dx.doi.org/10.1056/NEJMoa1108789.
17. NCCLS. 2003. Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes; approved standard. NCCLS document M24-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
18. Canetti G, Froman S, Grosset J, Hauduroy P, Langerová M, Mahler HT, Meissner G, Mitchison DA, Šula L. 1963. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 29:565-578.
19. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, Rist N, Smelev NA. 1969. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 41:21-43.
20. Kent PT, Kubica GP. 1985. Public health mycobacteriology: a guide for the level III laboratory. Centers for Disease Control and Prevention, Atlanta, GA.
21. Heifets L. 2000. Conventional methods for antimicrobial susceptibility testing of Mycobacterium tuberculosis, p 133-143. In Bastian I, Portaels F (ed), Multidrug-resistant tuberculosis. Kluwer Academic Publishers, Dordrecht, The Netherlands.
22. Laszlo A, Rahman M, Espinal M, Raviglione M, WHO/IUATLD Network of Supranational Reference Laboratories. 2002. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis 6:748-756.
23. Jin J, Shen Y, Fan X, Diao N, Wang F, Wang S, Weng X, Zhang W. 2013. Underestimation of the resistance of Mycobacterium tuberculosis to second-line drugs by the new GenoType MTBDRsl test. J Mol Diagn 15: 44-50. http://dx.doi.org/10.1016/j.jmoldx.2012.08.004.
24. Zhang Y, Yew WW. 2009. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 13:1320-1330.
25. Jin J, Zhang Y, Fan X, Diao N, Shao L, Wang F, Hu P, Wang S, Weng X, Zhang W. 2012. Evaluation of the GenoType MTBDRplus assay and identification of a rare mutation for improving MDR-TB detection. Int J Tuberc Lung Dis 16:521-526. http://dx.doi.org/10.5588/ijtld.11.0269.
26. Chen J, Tsolaki AG, Shen X, Jiang X, Mei J, Gao Q. 2007. Deletiontargeted multiplex PCR (DTM-PCR) for identification of Beijing/W genotypes of Mycobacterium tuberculosis. Tuberculosis (Edinb) 87:446-449. http://dx.doi.org/10.1016/j.tube.2007.05.014.
27. Zhang L, Chen J, Shen X, Gui X, Mei J, Deriemer K, Gao Q. 2008. Highly polymorphic variable-number tandem repeats loci for differentiating Beijing genotype strains of Mycobacterium tuberculosis in Shanghai, China. FEMS Microbiol Lett 282:22-31. http://dx.doi.org/10.1111/j.1574 -6968.2008.01081.x.
28. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, Schecter GF, Daley CL, Schoolnik GK. 1994. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 330:1703-1709.
29. Fang R, Li X, Li J, Wu J, Shen X, Gui X, DeRiemer K, Liu L, Mei J, Gao Q. 2008. Mixed infections of Mycobacterium tuberculosis in tuberculosis patients in Shanghai, China. Tuberculosis (Edinb) 88:469-473. http://dx .doi.org/10.1016/j.tube.2008.02.002.
30. Mei J, Shen X, Zha J, Sun B, Shen M, Shen GM, Gao Q. 2005. Study on the molecular epidemiology of Mycobacterium tuberculosis in Shanghai. Zhonghua Liu Xing Bing Xue Za Zhi 26:707e10. (In Chinese.)
31. Wang F, Massire C, Li H, Cummins LL, Li F, Jin J, Fan X, Wang S, Shao L, Zhang S, Meng S, Wu J, Lu C, Blyn LB, Sampath R, Ecker DJ, Zhang W, Tang YW. 2011. Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates circulating in China by multilocus PCR and electrospray ionization mass spectrometry. J Clin Microbiol 49:2719-2721. http://dx.doi.org/10.1128/JCM.00317-11.
32. Li X, Zhang Y, Shen X, Shen G, Gui X, Sun B, Mei J, Deriemer K, Small PM, Gao Q. 2007. Transmission of drug resistant tuberculosis among treated patients in Shanghai, China. J Infect Dis 195:864-869. http://dx .doi.org/10.1086/511985.
33. Andrews JR, Gandhi NR, Moodley P, Shah NS, Bohlken L, Moll AP, Pillay M, Friedland G, Sturm AW, Tugela Ferry Care and Research Collaboration. 2008. Exogenous reinfection as a cause of multidrugresistant and extensively drug-resistant tuberculosis in rural South Africa. J Infect Dis 198:1582-1589. http://dx.doi.org/10.1086/592991.
34. Zignol M, van Gemert W, Falzon D, Sismanidis C, Glaziou P, Floyd K, Raviglione M. 2012. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull World Health Organ 90: 111-119. http://dx.doi.org/10.2471/BLT.11.092585.
35. Barry PM, Gardner TJ, Funk E, Oren E, Field K, Shaw T, Langer AJ. 2012. Multistate outbreak of MDR TB identified by genotype cluster investigation. Emerging Infect Dis 18:11. http://dx.doi.org/10.3201/eid1801 .110671.
36. Cohen T, Murray M, Abubakar I, Zhang Z, Sloutsky A, Arteaga F, Chalco K, Franke MF, Becerra MC. 2011. Multiple introductions of multidrug-resistant tuberculosis into households, Lima, Peru. Emerging Infect Dis 17:969-975. http://dx.doi.org/10.3201/eid/1706.101471.
37. Gavín P, Iglesias MJ, Jiménez MS, Rodríguez-Valín E, Ibarz D, Lezcano MA, Revillo MJ, Martín C, Samper S, Spanish Working Group on MDR-TB. 2012. Long-term molecular surveillance of multidrug-resistant tuberculosis in Spain. Infect Genet Evol 12:701-710. http://dx.doi.org/10 .1016/j.meegid.2011.05.016.
38. Kruijshaar ME, Watson JM, Drobniewski F, Anderson C, Brown TJ, Magee JG, Smith EG, Story A, Abubakar I. 2008. Increasing antituberculosis drug resistance in the United Kingdom: analysis of national surveillance data. BMJ 336:1231-1234. http://dx.doi.org/10.1136/bmj.39546 .573067.25.
39. Jeon CY, Hwang SH, Min JH, Prevots DR, Goldfeder LC, Lee H, Eum SY, Jeon DS, Kang HS, Kim JH, Kim BJ, Kim DY, Holland SM, Park SK, Cho SN, Barry CE, III, Via LE. 2008. Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital. Clin Infect Dis 46:42-49. http://dx .doi.org/10.1086/524017.
40. Perdigão J, Macedo R, Silva C, Machado D, Couto I, Viveiros M, Jordao L, Portugal I. 2013. From multidrug-resistant to extensively drugresistant tuberculosis in Lisbon, Portugal: the stepwise mode of resistance acquisition. J Antimicrob Chemother 68:27-33. http://dx.doi.org/10.1093 /jac/dks371.
41. Casali N, Nikolayevskyy V, Balabanova Y, Harris SR, Ignatyeva O, Kontsevaya I, Corander J, Bryant J, Parkhill J, Nejentsev S, Horstmann RD, Brown T, Drobniewski F. 2014. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat Genet 46:279-286. http://dx.doi.org/10.1038/ng.2878.